Search Results - "Timur Naim"

Refine Results
  1. 1

    Defective fasting-induced PKA activation impairs adipose tissue glycogen degradation in obese Zucker rats by Flores-Opazo, Marcelo, Trieu, Jennifer, Naim, Timur, Valladares-Ide, Denisse, Zbinden-Foncea, Hermann, Stapleton, David

    Published in International Journal of Obesity (01-02-2020)
    “…Background Obesity is associated with development of insulin resistance in adipose tissue (AT). Human obesity has been associated with increased glycogen…”
    Get full text
    Journal Article
  2. 2

    Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer by Murphy, Kate T, Hossain, Mohammed I, Swiderski, Kristy, Chee, Annabel, Naim, Timur, Trieu, Jennifer, Haynes, Vanessa, Read, Suzannah J, Stapleton, David I, Judge, Sarah M, Trevino, Jose G, Judge, Andrew R, Lynch, Gordon S

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal muscle mass associated with significant functional impairment…”
    Get full text
    Journal Article
  3. 3

    Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice by Ham, Daniel J., Gardner, Anastasia, Kennedy, Tahnee L., Trieu, Jennifer, Naim, Timur, Chee, Annabel, Alves, Francesca M., Caldow, Marissa K., Lynch, Gordon S., Koopman, René

    Published in Scientific reports (10-09-2019)
    “…Duchenne muscular dystrophy (DMD) is an X-linked genetic disease characterized by progressive muscle wasting and weakness and premature death. Glucocorticoids…”
    Get full text
    Journal Article
  4. 4

    Deletion of suppressor of cytokine signaling 3 (SOCS3) in muscle stem cells does not alter muscle regeneration in mice after injury by Swiderski, Kristy, Caldow, Marissa K, Naim, Timur, Trieu, Jennifer, Chee, Annabel, Koopman, René, Lynch, Gordon S

    Published in PloS one (27-02-2019)
    “…Muscles of older animals are more susceptible to injury and regenerate poorly, in part due to a persistent inflammatory response. The janus kinase (Jak)/signal…”
    Get full text
    Journal Article
  5. 5

    Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice by Murphy, Kate T, Chee, Annabel, Gleeson, Ben G, Naim, Timur, Swiderski, Kristy, Koopman, René, Lynch, Gordon S

    “…Cancer cachexia describes the progressive skeletal muscle wasting and weakness in many cancer patients and accounts for >20% of cancer-related deaths. We…”
    Get more information
    Journal Article
  6. 6

    The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy by Swiderski, Kristy, Chan, Audrey S, Herold, Marco J, Kueh, Andrew J, Chung, Jin D, Hardee, Justin P, Trieu, Jennifer, Chee, Annabel, Naim, Timur, Gregorevic, Paul, Lynch, Gordon S

    Published in Disease models & mechanisms (01-04-2024)
    “…Duchenne muscular dystrophy (DMD) is a devastating monogenic skeletal muscle-wasting disorder. Although many pharmacological and genetic interventions have…”
    Get full text
    Journal Article
  7. 7

    Antibody‐directed myostatin inhibition in 21‐mo‐old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function by Murphy, Kate T., Koopman, René, Naim, Timur, Léger, Bertrand, Trieu, Jennifer, Ibebunjo, Chikwendu, Lynch, Gordon S.

    Published in The FASEB journal (01-11-2010)
    “…ABSTRACTSarcopenia is the progressive loss of skeletal muscle mass and function with advancing age, leading to reduced mobility and quality of life. We tested…”
    Get full text
    Journal Article
  8. 8

    Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia by Murphy, Kate T, Chee, Annabel, Trieu, Jennifer, Naim, Timur, Lynch, Gordon S

    Published in Disease models & mechanisms (01-07-2012)
    “…Cancer cachexia describes the progressive skeletal muscle wasting and weakness that is associated with many cancers. It impairs quality of life and accounts…”
    Get full text
    Journal Article
  9. 9

    Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in mdx Dystrophic Mice by Swiderski, Kristy, Read, Suzannah J, Chan, Audrey S, Chung, Jin D, Trieu, Jennifer, Naim, Timur, Koopman, René, Lynch, Gordon S

    Published in Nutrients (20-12-2021)
    “…Gastrointestinal (GI) dysfunction is an important, yet understudied condition associated with Duchenne muscular dystrophy (DMD), with patients reporting…”
    Get full text
    Journal Article
  10. 10

    Dystrophin S3059 phosphorylation partially attenuates denervation atrophy in mouse tibialis anterior muscles by Swiderski, Kristy, Naim, Timur, Trieu, Jennifer, Chee, Annabel, Herold, Marco J., Kueh, Andrew J., Goodman, Craig A., Gregorevic, Paul, Lynch, Gordon S.

    Published in Physiological reports (01-07-2024)
    “…The dystrophin protein has well‐characterized roles in force transmission and maintaining membrane integrity during muscle contraction. Studies have reported…”
    Get full text
    Journal Article
  11. 11

    Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice by Stapleton, David I, Lau, Xianzhong, Flores, Marcelo, Trieu, Jennifer, Gehrig, Stefan M, Chee, Annabel, Naim, Timur, Lynch, Gordon S, Koopman, René

    Published in PloS one (13-03-2014)
    “…Duchenne muscular dystrophy (DMD) is a severe, genetic muscle wasting disorder characterised by progressive muscle weakness. DMD is caused by mutations in the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Functional β-adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiation by Church, Jarrod E, Trieu, Jennifer, Sheorey, Radhika, Chee, Annabel Y-M, Naim, Timur, Baum, Dale M, Ryall, James G, Gregorevic, Paul, Lynch, Gordon S

    Published in PloS one (07-07-2014)
    “…Muscles can be injured in different ways and the trauma and subsequent loss of function and physical capacity can impact significantly on the lives of patients…”
    Get full text
    Journal Article
  15. 15

    Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury by Murphy, Kate T, Allen, Andrew M, Chee, Annabel, Naim, Timur, Lynch, Gordon S

    “…The role of the renin-angiotensin system (RAS) in vasoregulation is well established, but a localized RAS exists in multiple tissues and exerts diverse…”
    Get more information
    Journal Article
  16. 16

    Mechanisms of chemotherapy‐induced muscle wasting in mice with cancer cachexia by Murphy, Kate T., Swiderski, Kristy, Ryall, James G., Davey, Jonathan R., Qian, Hongwei, Lamon, Séverine, Foletta, Victoria C., Trieu, Jennifer, Chee, Annabel, Read, Suzannah J., Naim, Timur, Gregorevic, Paul, Lynch, Gordon S.

    Published in JCSM rapid communications (01-01-2022)
    “…Background Cachexia is a debilitating complication of cancer characterized by progressive wasting and weakness of skeletal muscles that reduces quality of life…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Deletion of suppressor of cytokine signaling 3 by Swiderski, Kristy, Caldow, Marissa K, Naim, Timur, Trieu, Jennifer, Chee, Annabel, Koopman, René, Lynch, Gordon S

    Published in PloS one (27-02-2019)
    “…Muscles of older animals are more susceptible to injury and regenerate poorly, in part due to a persistent inflammatory response. The janus kinase (Jak)/signal…”
    Get full text
    Journal Article
  20. 20

    The BALB/c. mdx 62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy by Swiderski, Kristy, Chan, Audrey S., Herold, Marco J., Kueh, Andrew J., Chung, Jin D., Hardee, Justin P., Trieu, Jennifer, Chee, Annabel, Naim, Timur, Gregorevic, Paul, Lynch, Gordon S.

    Published in Disease models & mechanisms (01-04-2024)
    “…ABSTRACT Duchenne muscular dystrophy (DMD) is a devastating monogenic skeletal muscle-wasting disorder. Although many pharmacological and genetic interventions…”
    Get full text
    Journal Article